Putnam Investments LLC Amylyx Pharmaceuticals, Inc. Transaction History

Putnam Investments LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$18.08 - $23.45 $7,268 - $9,426	-402 Reduced 0.86%	46,460 $850,000
Q2 2023 Aug 14, 2023	SELL	$20.98 - $31.42 $30,609 - $45,841	-1,459 Reduced 3.02%	46,862 $1.01 Million
Q1 2023 May 22, 2023	BUY	$27.71 - $40.93 $700,758 - $1.04 Million	25,289 Added 109.8%	48,321 $1.42 Million
Q4 2022 Feb 14, 2023	SELL	$29.75 - $39.26 $386 - $510	-13 Reduced 0.06%	23,032 $851,000
Q3 2022 Nov 14, 2022	BUY	$17.15 - $30.92 $395,221 - $712,551	23,045 New	23,045 $649,000

127

44.4M

235K

530K

Ticker AMLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,533,200
Market Cap $310M
Description
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.